Safety, Ethics & Fundamentals
TMS application guidance, safety consideration and procedures.
Scientific content remains the intellectual property of the authors. Magstim does not engage in generating, or editing scientific content presented in this Knowledge Center. Inclusion in the Knowledge Center should not be taken as an endorsement of scientific findings by Magstim. Please note: the use of Magstim devices for other than the cleared intended use is considered investigational.
Therapeutic TMS Application Guidance
Therapeutic TMS Application Guidance
A group of European experts reappraised the guidelines on the therapeutic efficacy of repetitive transcranial magnetic stimulation (rTMS) previously published in 2014 [Lefaucheur et al., Clin Neurophysiol 2014;125:2150–206]. These updated recommendations take into account all rTMS publications, including data prior to 2014, as well as currently reviewed literature until the end of 2018.
TMS Safety Considerations
TMS Safety Considerations
This article is based on a consensus conference, promoted and supported by the International Federation of Clinical Neurophysiology (IFCN), which took place in Siena (Italy) in October 2018. The meeting intended to update the ten-year-old safety guidelines for the application of transcranial magnetic stimulation (TMS) in research and clinical settings (Rossi et al., 2009).
